Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
AMC Global Media Inc. reported its Q2 2026 financial results, emphasizing a new global co-exclusive content licensing agreement with Netflix for the streaming rights to the entire Walking Dead Universe, generating $500 million over five years. While the company renewed key distribution agreements and increased full-year guidance, Q2 revenues declin…
Mangoceuticals, Inc. has entered into a business combination agreement with Nuclea Energy Inc., a Canadian advanced nuclear technology firm developing the Morpheus lead-cooled microreactor. The transaction will bring Nuclea public via Mangoceuticals’ Nasdaq listing, supporting Nuclea's advancement toward commercialization amid growing electricity d…
Beyond Air, a NASDAQ-listed commercial-stage medical device and biopharmaceutical company, announced a private placement offering of up to $30.1 million at-the-market under Nasdaq rules. The financing involves the sale of common stock, pre-funded warrants, and accompanying Series A and B warrants to institutional healthcare investors and company in…
HUTCHMED reported robust growth in China product sales led by ELUNATE® and SULANDA®, with over 40% sales increase, and strong ex-US sales growth for FRUZAQLA®. The company maintained profitability with $15.9 million net income amid higher R&D investment and a strong cash position of $1.37 billion. Multiple first-in-class Antibody-Targeted Therapy C…
Allegro MicroSystems, Inc. announced its financial results for the first quarter of fiscal 2027, showing strong momentum with $259 million in sales, a 27% year-over-year increase. The company returned to profitability with GAAP EPS of $0.08 compared to a loss the prior year, and non-GAAP EPS grew over 2.5 times to $0.23. Growth was led by data cent…
Shoals Technologies Group, a Nasdaq-listed leader in electrical infrastructure for the energy transition market, announced its participation in several upcoming virtual and in-person investor events hosted by prominent financial institutions between August and October 2026. These events will involve fireside chats, conferences, and roadshows focuse…
Colliers International Group Inc. announced robust second quarter 2026 financial results, showing a 17% increase in consolidated revenues to $1.57 billion and a 14% rise in Adjusted EBITDA to $205.3 million compared to Q2 2025. Adjusted EPS increased 6% to $1.83. The company's diversified business model continues to fuel growth across Commercial Re…
Wrap Technologies, Inc. announced that Stark Security Inc. will deploy WRAP's immersive virtual reality training platform, Wrap Reality, for officer training across multiple Midwest states. This strategic move marks WRAP's deeper expansion into the private security market, leveraging VR training to improve decision-making, de-escalation, and risk r…
Codere Online reported record second quarter financial results with net gaming revenue up 27% year-over-year to €69.4 million and Adjusted EBITDA more than doubling to €5.8 million. The company saw strong growth in its core markets of Spain and Mexico, driven in part by heightened betting activity during the World Cup. With a cash position of €62.6…
Ultralife Corporation (NASDAQ: ULBI) announced it will release its second quarter 2026 financial results on August 7, 2026, before the market opens, followed by an investor conference call and webcast. The company specializes in power solutions and communication systems serving government, defense, and commercial sectors globally.
INmune Bio has established a Scientific Advisory Board composed of global experts to support the late-stage clinical and regulatory development of Ebstrocel, a treatment for recessive dystrophic epidermolysis bullosa (RDEB), and to guide expansion of its proprietary CORDStrom™ mesenchymal stromal cell platform into new therapeutic areas. The SAB wi…
Immunocore Holdings plc announced that it will release its financial results for the second quarter of 2026 on August 6, 2026, followed by a live webcast and conference call to discuss the results and provide updates on its business and portfolio. The company is a commercial-stage biotech focused on novel immunotherapies targeting cancer, infectiou…
Bristol Myers Squibb reported second-quarter revenue and adjusted earnings that beat analyst expectations, prompting the company to raise its full-year revenue guidance and increase its 2026 adjusted earnings forecast. Powerful sales of the blood thinner Eliquis and several recently launched medicines - including Camzyos, Reblozyl and Breyanzi - un…
Darling Ingredients' shares jumped in pre-market trading after the company reported second-quarter earnings that far surpassed analyst expectations. The company posted EPS of $2.41 versus a $1.27 estimate, creating a sizeable earnings surprise that outweighed a revenue miss. Market and analyst sentiment provided additional support ahead of the comp…
Affiliated Managers Group, Inc. (NYSE: AMG) announced robust financial and operational results for Q2 and the first half of 2026. The company reported a 54% year-over-year increase in Economic EPS to $8.29 for Q2, driven by growth in alternative investment strategies and disciplined capital allocation. Assets under management reached a record $942 …
Phathom Pharmaceuticals announced an 88% year-over-year increase in Q2 2026 net revenues to $74.3 million driven by growth in VOQUEZNA prescriptions. The company reduced operating expenses by 33% compared to Q2 2025 and achieved operating profitability excluding stock-based compensation. Phathom plans to initiate a Phase 3 clinical trial evaluating…
KKR reported higher management fees, stronger realized gains from asset sales and substantial fresh capital flows in the second quarter, driving adjusted net income to $1.63 per share. The firm saw growth across private equity, credit and real assets, and completed multiple portfolio exits while advancing a major renewables acquisition.
Ferrari N.V. announced robust second quarter 2026 financial results, highlighting an 8% revenue increase with significant contributions from personalized vehicle options and a favorable product mix. Operating profit rose 10%, and net income increased notably. Ferrari raised its full-year 2026 guidance, reflecting stronger personalization demand and…
U.S. stock futures were steady after a sharp market selloff tied to uncertainty over Federal Reserve policy. Microsoft’s stronger-than-expected earnings, an upbeat near-term sales and cloud outlook, and a capital expenditure plan below analyst estimates helped soothe investor worries about rising AI-related costs at major tech firms. Still, mixed s…
Martin Marietta Materials, Inc. reported second-quarter 2026 results with a 21% increase in revenues to a new record of $1.947 billion and a 13% growth in adjusted EBITDA from continuing operations. The company raised its full-year 2026 revenue guidance to $7.2 billion to $7.4 billion while reaffirming adjusted EBITDA guidance. Key initiatives incl…
Butterfly Network's stock climbed nearly 6% in pre-market trading after the company reported second-quarter 2026 results. The firm posted an EPS loss of $0.01, beating the consensus loss of $0.04, while revenue of $15.72 million fell well short of the roughly $29.15 million analysts expected. Investors appeared to focus on the narrowing loss trajec…
Xenia Hotels & Resorts (XHR) climbed 2.0% in pre-market trading after reporting second-quarter 2026 results that missed consensus on both revenue and GAAP earnings. Market participants appeared to prioritize funds-from-operations and operational trends such as RevPAR growth and group demand over GAAP EPS, which was affected by depreciation. The sto…
Gilead looks like a buy here: headline-driven weakness has created a tactical entry opportunity ahead of the company’s Q2 update and several near-term catalysts. The risk/reward is attractive if you size appropriately and use a disciplined stop. This trade is sized for a mid-term horizon where fundamentals and guidance revisions should re-price the…
ADT Inc. reported second quarter 2026 results showing a 2% revenue increase to $1.3 billion, significant cash flow growth with operating cash flow up 18% and adjusted free cash flow up 48%. The company repurchased $478 million of shares and returned $684 million to shareholders in the first half of 2026. ADT raised its full-year 2026 financial outl…
Xcel Energy shares climbed 2.1% in pre-open trading after the utility reported second-quarter 2026 earnings that exceeded analyst expectations on earnings per share while missing on revenue. Management reiterated full-year guidance and the board approved a quarterly dividend, with healthy demand and recent rate actions cited as contributors to earn…
